Top 10 Safest Stocks To Watch Right Now

tags:ANTX,VLRS,PSMT,HLX,CLWT,COLL,CATB,EVA,PRTS,FV, Currencies, commodities, different stock sectors, and bonds...   For the last few days, they've been all over the place.   Investors and traders are digesting the news. They're trying to figure out what "President Trump" means for the world. They're trying to figure out where their money is safest... and where they'll make the biggest profits.   Today, we'll look at a few areas of the market that are likely to do well under Trump...   I'll start with infrastructure. Trump plans to spend big to improve things like roads and bridges in the U.S. He has experience with construction. And he'll likely follow through on his promises here.   That bodes well for companies that produce building materials like stone, gravel, steel, and copper. Just look at the price action of companies like Martin Marietta Materials (MLM), Vulcan Materials (VMC), U.S. Steel (X), and Freeport-McMoRan (FCX) since the election. They've all shot higher.

Top 10 Safest Stocks To Watch Right Now: Anthem, Inc.(ANTX)

Advisors' Opinion:

• [By Max Byerly]

  Antimatter (CURRENCY:ANTX) traded 10.9% lower against the US dollar during the twenty-four hour period ending at 19:00 PM E.T. on June 10th. One Antimatter coin can now be purchased for approximately $0.0001 or 0.00000002 BTC on exchanges. During the last seven days, Antimatter has traded 12.5% lower against the US dollar. Antimatter has a market cap of $0.00 and $7.00 worth of Antimatter was traded on exchanges in the last 24 hours.

• [By Logan Wallace]

  Antimatter (CURRENCY:ANTX) traded flat against the U.S. dollar during the one day period ending at 12:00 PM E.T. on July 22nd. In the last seven days, Antimatter has traded up 17.8% against the U.S. dollar. Antimatter has a total market capitalization of $0.00 and $1.00 worth of Antimatter was traded on exchanges in the last 24 hours. One Antimatter coin can currently be bought for $0.0001 or 0.00000001 BTC on popular cryptocurrency exchanges.

Top 10 Safest Stocks To Watch Right Now: Controladora Vuela Compania de Aviacion, S.A.B. de C.V.(VLRS)

Advisors' Opinion:

• [By Adam Levine-Weinberg]

  In late 2016 and early 2017, profitability deteriorated rapidly at Mexican budget airline Volaris (NYSE:VLRS) due to market disruptions caused by the U.S. presidential election. Fears about a crackdown on trade or immigration under President Trump led to a sharp drop in the Mexican peso and a downturn in travel demand. However, Volaris seemed to be on the mend by this time last year, and its stock price rebounded to more than $15 last July.

• [By Max Byerly]

  Volaris (NYSE:VLRS)’s share price hit a new 52-week high and low during trading on Wednesday . The stock traded as low as $5.07 and last traded at $5.22, with a volume of 64285 shares trading hands. The stock had previously closed at $5.19.

• [By Lisa Levin]

  Check out these big penny stock gainers and losers

  Losers Prothena Corporation plc (NASDAQ: PRTA) shares dipped 69 percent to $11.48 after a disappointing update relating to the company's treatment for AL amyloidosis. Prothena, a clinical-stage biopharmaceutical company that focuses on therapies in the neuroscience and orphan categories, said a Phase 2b study of its therapy called NEOD001 failed to achieve its primary or secondary endpoints. Prothena's Phase 2b study explored its NEOD001 therapy versus a placebo in previously-treated patients with AL amyloidosis and persistent cardiac dysfunction. Gridsum Holding Inc. (NASDAQ: GSUM) fell 44.3 percent to $4.06. Gridsum reported suspension of audit report on financial statements. Flotek Industries, Inc. (NYSE: FTK) shares declined 34.1 percent to $4.16 as the company issued weak revenue forecast for the first quarter. Akorn, Inc. (NASDAQ: AKRX) dropped 32.3 percent to $13.35 after Fresenius terminated its merger deal with Akorn. Chicago Bridge & Iron Company N.V. (NYSE: CBI) fell 31.2 percent to $13.44. Subsea 7 made an unsolicited bid to buy McDermott for $7 per share. However, the acquisition offer is contingent on McDermot terminating its pending merger with Chicago Bridge & Iron. Controladora Vuela Compañía de Aviación, S.A.B. de C.V. (NYSE: VLRS) dropped 18 percent to $5.76. Controladora Vuela recently reported first-quarter results that showed a loss for the quarter. Imperial Capital downgraded Controladora Vuela Compania de Aviacion from Outperform to In-Line. Atossa Genetics Inc. (NASDAQ: ATOS) fell 18.2 percent to $2.8797 after declining 19.35 percent on Friday. Alcoa Corporation (NYSE: AA) fell 12.3 percent to $52.63. Luby's, Inc. (NYSE: LUB) shares declined 10.3 percent to $2.448 following Q2 results. Aceto Corporation (NASDAQ: ACET) shares tumbled 10 percent to $2.26. Pier 1 Imports, Inc. (NYSE: PIR) dipped 9.7 percent
• [By Travis Hoium]

  Shares of Mexican airline Controladora Vuela Co Avcn SA CV (NYSE:VLRS) plunged as much as 20.3% in trading Monday after announcing earnings that led to fears of growing competition. At 12:25 p.m. EDT shares were still down 16.6% on the day. 

• [By Shane Hupp]

  Get a free copy of the Zacks research report on Controladora Vuela Co Avcn SA CV (VLRS)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Safest Stocks To Watch Right Now: PriceSmart, Inc.(PSMT)

Advisors' Opinion:

• [By Max Byerly]

  Get a free copy of the Zacks research report on PriceSmart (PSMT)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Demitrios Kalogeropoulos]

  International warehouse club PriceSmart (NASDAQ:PSMT) has seen its fortunes improve recently as economic growth rates steadied in many of its core Latin American, Caribbean, and Central American markets. The retailer is also benefiting from a sharp rebound in the value of the local Colombian currency.

• [By Demitrios Kalogeropoulos]

  The week ahead is shortened by the July 4 holiday, but still includes a few big-name earnings reports that could move individual stocks. Below, we'll preview what investors will be focusing on with these announcements from Herman Miller (NASDAQ:MLHR), Acuity Brands (NYSE:AYI), and PriceSmart (NASDAQ:PSMT).

• [By Ethan Ryder]

  PriceSmart (NASDAQ: PSMT) is one of 12 publicly-traded companies in the “Variety stores” industry, but how does it compare to its rivals? We will compare PriceSmart to similar companies based on the strength of its dividends, institutional ownership, risk, earnings, analyst recommendations, profitability and valuation.

Top 10 Safest Stocks To Watch Right Now: Helix Energy Solutions Group, Inc.(HLX)

Advisors' Opinion:

• [By Logan Wallace]

  Get a free copy of the Zacks research report on Helix Energy Solutions Group (HLX)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Stephan Byrd]

  Helix Energy Solutions Group (NYSE:HLX) was downgraded by investment analysts at ValuEngine from a “buy” rating to a “hold” rating in a research report issued on Friday.

• [By Lisa Levin] Gainers SemiLEDs Corporation (NASDAQ: LEDS) shares rose 35.8 percent to $4.55. EVINE Live Inc. (NASDAQ: EVLV) gained 28.8 percent to $1.04. The pay-TV home shopping company was named as a potential acquisition target by TechCrunch. According to the publication, Amazon.com, Inc. (NASDAQ: AMZN) is exploring ways of marketing its products and services to consumers beyond the internet. Sanmina Corp (NASDAQ: SANM) shares surged 19.1 percent to $33.00 as the company reported stronger-than-expected earnings for its second quarter on Monday. Heidrick & Struggles International, Inc. (NASDAQ: HSII) gained 14.9 percent to $37.22 as the company posted upbeat results for its first quarter. Santander Consumer USA Holdings Inc. (NYSE: SC) shares climbed 14 percent to $17.90 following upbeat quarterly earnings. Helix Energy Solutions Group, Inc. (NYSE: HLX) climbed 14 percent to $7.12 following strong quarterly results. Check-Cap Ltd. (NASDAQ: CHEK) gained 13.6 percent to $8.25. Atossa Genetics Inc. (NASDAQ: ATOS) rose 11.8 percent to $3.34. Atossa Genetics disclosed that it has Received positive interim review from the Independent Safety Committee in Phase 1 Topical endoxifen dose escalation study in men. Cadence Design Systems, Inc. (NASDAQ: CDNS) gained 11.6 percent to $40.99 after the company posted upbeat Q1 results and issued a strong Q2 forecast. Genprex, Inc. (NASDAQ: GNPX) climbed 11.2 percent to $4.9363. Mitel Networks Corporation (NASDAQ: MITL) rose 10.5 percent to $11.23 after the company agreed to be acquired by affiliates of Searchlight Capital Partners for $2.0 billion. Systemax Inc. (NYSE: SYX) rose 10.2 percent to $30.86. Sidoti & Co. upgraded Systemax from Neutral to Buy. Orchids Paper Products Company (NYSE: TIS) surged 9.2 percent to $7.13. Orchids Paper Products is expected to report its Q1 financial results on Wednesday, April 25, 2018. New Oriental Education & Technology Group Inc. (NYSE: EDU) rose

Top 10 Safest Stocks To Watch Right Now: Euro Tech Holdings Company Limited(CLWT)

Advisors' Opinion:

• [By Lisa Levin]

  Euro Tech Holdings Company Limited (NASDAQ: CLWT) was down, falling around 7 percent to $3.745 after dropping 30.26 percent on Friday.

  Commodities

• [By Lisa Levin] Gainers Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares rose 14.1 percent to $3.65 in the pre-market trading session after reporting 2017 year-end results. LightPath Technologies, Inc. (NASDAQ: LPTH) rose 13.3 percent to $2.43 in pre-market trading after reporting a third-quarter earnings beat. MYnd Analytics, Inc. (NASDAQ: MYND) rose 10.5 percent to $3.49 in pre-market trading. MYnd Analytics reported a Q2 net loss of $2.7 million on revenue of $459,900. SORL Auto Parts, Inc. (NASDAQ: SORL) shares rose 8.4 percent to $5.68 in pre-market trading after reporting upbeat Q1 results. Famous Dave's of America, Inc. (NASDAQ: DAVE) shares rose 7.7 percent to $8.40 in pre-market trading after the company reported upbeat earnings for its first quarter on Monday. Xenon Pharmaceuticals Inc. (NASDAQ: XENE) rose 7.5 percent to $6.45 in pre-market trading after the company presented XEN901 Phase 1 clinical update and XEN1101 TMS pharmacodynamic Phase 1 data. Mimecast Ltd (NASDAQ: MIME) rose 6.5 percent to $43.50 in pre-market trading following a first-quarter sales beat. Boxlight Corporation (NASDAQ: BOXL) rose 6 percent to $12.50 in pre-market trading after surging 77.44 percent on Monday. Intellia Therapeutics, Inc. (NASDAQ: NTLA) shares rose 6 percent to $26.05 in pre-market trading after climbing 3.58 percent on Monday. PPDAI Group Inc. (NASDAQ: PPDF) rose 4.7 percent to $7.20 in pre-market trading following Q1 results. Xunlei Limited (NASDAQ: XNET) rose 4.1 percent to $13.88 in pre-market trading after gaining 2.54 percent on Monday. Valeant Pharmaceuticals International, Inc. (NYSE: VRX) shares rose 4.5 percent to $21.73 in pre-market trading. Mizuho upgraded Valeant from Neutral to Buy. Bovie Medical Corporation (NYSE: BVX) rose 4.1 percent to $3.80 in pre-market trading after reporting a first-quarter sales beat. Myomo, Inc. (NYSE: MYO) rose 3.4 percent to $4.00 in pre-market trading after jumping 23.25 percent o
• [By Lisa Levin]

  Check out these big penny stock gainers and losers

  Losers Verastem, Inc. (NASDAQ: VSTM) fell 9.7 percent to $4.73 in pre-market trading after announcing a $35 million common stock offering. Evolus, Inc. (NASDAQ: EOLS) shares fell 8 percent to $13.48 in pre-market trading ahead of regulatory update at 8:30 a.m. ET. XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB) fell 6.5 percent to $2.01 in pre-market trading after climbing 10.50 percent on Tuesday. Purple Innovation, Inc. (NASDAQ: PRPL) shares fell 5.8 percent to $9.36 in pre-market trading after reporting Q1 results. Blink Charging Co. (NASDAQ: BLNK) fell 5.7 percent to $5.15 in pre-market trading after declining 5.04 percent on Tuesday. RYB Education, Inc. (NYSE: RYB) shares fell 5 percent to $16.39 in pre-market trading following Q1 results. Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares fell 4.4 percent to $4.30 in pre-market trading after rising 40.62 percent on Tuesday. Arbor Realty Trust, Inc. (NYSE: ABR) fell 4.4 percent to $8.92 in pre-market trading after announcing a 5.5 million share common stock offering. Daxor Corporation (NYSE: DXR) fell 4.1 percent to $7.32 in pre-market trading. Ormat Technologies, Inc. (NYSE: ORA) shares fell 3.8 percent to $51.03 in pre-market trading after the company announced plans to restate its Q2, Q3, Q4 and FY 2017 financial statements. Canadian Solar Inc. (NASDAQ: CSIQ) fell 3.5 percent to $16.20 in pre-market trading after reporting Q1 results. CELYAD SA/ADR (NASDAQ: CYAD) shares fell 3.3 percent to $29.70 in pre-market trading after the company reported launch of 1.8 million share offering
• [By Lisa Levin]

  Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares shot up 49 percent to $4.775 after reporting 2017 year-end results.

  Shares of Medigus Ltd. (NASDAQ: MDGS) got a boost, shooting up 34 percent to $1.5092 in reaction to its Monday announcement of a distribution agreement. The medical device company said it reached an agreement to distribute its minimally invasive medical devices in Turkey, Azerbaijan and Georgia.

• [By Lisa Levin] Gainers Red Violet, Inc. (NASDAQ: RDVT) rose 75.31 percent to close at $9.94 after reporting Q1 results. Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares jumped 40.62 percent to close at $4.50 on Tuesday after reporting 2017 year-end results. MEI Pharma, Inc. (NASDAQ: MEIP) gained 34.39 percent to close at $3.40. MEDIGUS Ltd/S ADR (NASDAQ: MDGS) gained 32.74 percent to close at $1.50 in reaction to its Monday announcement of a distribution agreement. The medical device company said it reached an agreement to distribute its minimally invasive medical devices in Turkey, Azerbaijan and Georgia. Pfenex Inc. (NYSE: PFNX) surged 31.15 percent to close at $8.00 after the company announced the positive top-line PF708 study results in Osteoporosis patients that showed no imbalances in severity or incidence of adverse events. Arcadia Biosciences, Inc. (NASDAQ: RKDA) rose 21.07 percent to close at $11.09. Arcadia Biosciences reported that Albert D. Bolles, Ph.D. has joined its board of directors. Genprex, Inc. (NASDAQ: GNPX) rose 20.23 percent to close at $10.58. Turtle Beach Corporation (NASDAQ: HEAR) shares gained 17.62 percent to close at $17.82. Aptevo Therapeutics Inc. (NASDAQ: APVO) rose 17.1 percent to close at $5.82. Phoenix New Media Limited (NYSE: FENG) shares jumped 16.23 percent to close at $4.87 following Q1 earnings. Stein Mart, Inc. (NASDAQ: SMRT) rose 16.04 percent to close at $3.69. PPDAI Group Inc. (NASDAQ: PPDF) climbed 15.99 percent to close at $7.98 following Q1 results. Tyme Technologies, Inc. (NASDAQ: TYME) rose 15.93 percent to close at $3.42. LiqTech International, Inc. (NASDAQ: LIQT) gained 15.59 percent to close at $0.5532 following Q1 results. Sophiris Bio, Inc. (NASDAQ: SPHS) gained 13.92 percent to close at $3.52 on Tuesday following Q1 results. Euroseas Ltd. (NASDAQ: ESEA) jumped 13.4 percent to close at $2.37. Iteris, Inc. (NASDAQ: ITI) shares surged 13.05 percent to close
• [By Lisa Levin] Gainers Portola Pharmaceuticals, Inc. (NASDAQ: PTLA) rose 34.7 percent to $45.50 in pre-market trading following news that the FDA has approved Andexxa for the reversal of factor Xa inhibitors. Euro Tech Holdings Company Limited (NASDAQ: CLWT) rose 15.7 percent to $6.65 in pre-market trading after climbing 155.56 percent on Thursday. China Recycling Energy Corporation (NASDAQ: CREG) rose 14.7 percent to $2.75 in pre-market trading after climbing 57.89 percent on Thursday. Pandora Media, Inc. (NYSE: P) rose 11 percent to $6.40 in pre-market trading after reporting strong quarterly results. Fred's, Inc. (NASDAQ: FRED) rose 9.2 percent to $1.90 in pre-market trading following Q4 results. Shake Shack Inc (NYSE: SHAK) rose 9.1 percent to $51.70 in pre-market trading after the company reported upbeat results for its first quarter and raised its FY18 guidance. Allscripts Healthcare Solutions, Inc. (NASDAQ: MDRX) rose 9 percent to $12.55 in pre-market trading after the company posted Q1 results and agreed to acquire HealthGrid. Weight Watchers International, Inc. (NYSE: WTW) rose 7.6 percent to $75 in pre-market trading after the company reported stronger-than-expected results for its first quarter. The company also raised its FY18 earnings outlook from $2.40-$2.70 to $3-$3.20. Viavi Solutions Inc. (NASDAQ: VIAV) rose 7.5 percent to $10.15 in pre-market trading following Q3 results. Pearson plc (NYSE: PSO) rose 4.5 percent to $11.83 in pre-market trading after reporting strong quarterly earnings. Alibaba Group Holding Ltd (NYSE: BABA) shares rose 4.4 percent to $190.50 in the pre-market trading session as the company posted upbeat Q4 results. Aqua Metals, Inc. (NASDAQ: AQMS) shares rose 3.9 percent to $4.30 in pre-market trading after gaining 6.98 percent on Thursday. Newell Brands Inc (NYSE: NWL) shares rose 3.6 percent to $27.65 in pre-market trading after reporting upbeat quarterly earnings. HMS Holdings Corp (NASDAQ: H

Top 10 Safest Stocks To Watch Right Now: Collegium Pharmaceutical, Inc.(COLL)

Advisors' Opinion:

• [By Shane Hupp]

  Los Angeles Capital Management & Equity Research Inc. acquired a new position in Collegium Pharmaceutical Inc (NASDAQ:COLL) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund acquired 16,100 shares of the specialty pharmaceutical company’s stock, valued at approximately $384,000.

• [By Todd Campbell]

  Depomed is in the middle of a restructuring of its business that includes out-licensing its lead drug, Nucynta. In December, Collegium (NASDAQ:COLL) cut a licensing deal for Nucynta that guarantees Depomed $135 million in annual royalties, paid quarterly in arrears, for four years. If sales exceed $233 million per year, then Collegium Pharmaceutical will also pay Depomed a double-digit royalty on top of the minimum license fee. After four years, Depomed will receive double-digit royalties on all net Nucynta sales.

• [By Max Byerly]

  Collegium Pharmaceutical Inc (NASDAQ:COLL) shares were up 6.5% during trading on Friday . The stock traded as high as $15.15 and last traded at $14.79. Approximately 511,962 shares traded hands during trading, an increase of 20% from the average daily volume of 425,396 shares. The stock had previously closed at $13.89.

• [By Joseph Griffin]

  State Board of Administration of Florida Retirement System acquired a new stake in shares of Collegium Pharmaceutical Inc (NASDAQ:COLL) in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 10,174 shares of the specialty pharmaceutical company’s stock, valued at approximately $260,000.

• [By Logan Wallace]

  Collegium Pharmaceutical (NASDAQ:COLL) – Piper Jaffray lowered their FY2021 EPS estimates for shares of Collegium Pharmaceutical in a note issued to investors on Wednesday, May 9th. Piper Jaffray analyst D. Amsellem now forecasts that the specialty pharmaceutical company will post earnings per share of $2.06 for the year, down from their previous forecast of $2.32. Piper Jaffray has a “Buy” rating and a $33.00 price target on the stock.

Top 10 Safest Stocks To Watch Right Now: Catabasis Pharmaceuticals, Inc.(CATB)

Advisors' Opinion:

• [By Max Byerly]

  These are some of the news articles that may have effected Accern’s analysis:

  Get Catabasis Pharmaceuticals alerts: Market Trends Toward New Normal in Church & Dwight Co., Rent-A-Center, Teradata, Catabasis Pharmaceuticals, Tronox, and Callaway Golf — Emerging Consolidated Expectations, Analyst Ratings (finance.yahoo.com) Catabasis Pharmaceuticals Inc. – Receive News & Ratings Daily (thecasualsmart.com) Catabasis Pharmaceuticals (CATB) Upgraded by ValuEngine to Sell (americanbankingnews.com) Catabasis Pharmaceuticals to Report First Quarter 2018 Financial Results and Recent Corporate Developments on Thursday, May 10 (finance.yahoo.com) Catabasis Pharmaceuticals Inc (CATB) Given Consensus Rating of “Buy” by Brokerages (americanbankingnews.com)

  A number of analysts recently issued reports on CATB shares. Zacks Investment Research raised Catabasis Pharmaceuticals from a “hold” rating to a “buy” rating and set a $1.75 target price on the stock in a research report on Friday, January 26th. Wedbush reaffirmed an “outperform” rating and issued a $4.00 target price (down previously from $5.00) on shares of Catabasis Pharmaceuticals in a research report on Wednesday, February 14th. Finally, ValuEngine raised Catabasis Pharmaceuticals from a “strong sell” rating to a “sell” rating in a research report on Wednesday, May 2nd. One analyst has rated the stock with a sell rating, one has given a hold rating and six have assigned a buy rating to the stock. Catabasis Pharmaceuticals presently has a consensus rating of “Buy” and a consensus target price of $5.18.

• [By Ethan Ryder]

  Press coverage about Catabasis Pharmaceuticals (NASDAQ:CATB) has been trending somewhat positive recently, according to Accern. The research firm identifies negative and positive press coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Catabasis Pharmaceuticals earned a media sentiment score of 0.05 on Accern’s scale. Accern also assigned news articles about the biotechnology company an impact score of 44.9364257314523 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near term.

• [By Shane Hupp]

  Catabasis Pharmaceuticals Inc (NASDAQ:CATB) traded down 7.2% during trading on Wednesday . The company traded as low as $0.63 and last traded at $0.64. 738,517 shares traded hands during trading, a decline of 6% from the average session volume of 787,009 shares. The stock had previously closed at $0.69.

• [By Max Byerly]

  Press coverage about Catabasis Pharmaceuticals (NASDAQ:CATB) has been trending somewhat positive recently, Accern reports. The research firm identifies negative and positive media coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Catabasis Pharmaceuticals earned a media sentiment score of 0.14 on Accern’s scale. Accern also gave press coverage about the biotechnology company an impact score of 47.6345851568851 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.

Top 10 Safest Stocks To Watch Right Now: Enviva Partners, LP(EVA)

Advisors' Opinion:

• [By Max Byerly]

  Kayne Anderson Capital Advisors LP lifted its holdings in Enviva Partners LP (NYSE:EVA) by 94.2% during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 445,600 shares of the energy company’s stock after purchasing an additional 216,168 shares during the period. Kayne Anderson Capital Advisors LP’s holdings in Enviva Partners were worth $12,960,000 at the end of the most recent reporting period.

• [By Stephan Byrd]

  Enviva Partners (NYSE:EVA) had its price objective trimmed by Royal Bank of Canada to $33.00 in a research note issued to investors on Monday. The firm currently has an outperform rating on the energy company’s stock.

• [By Tyler Crowe, Sean Williams, and Brian Stoffel]

  So we asked three Motley Fool contributors to highlight a stock they think is a great dividend investment today. Here's why they picked Big Lots (NYSE:BIG), Enviva Partners (NYSE:EVA), and TerraForm Power (NASDAQ:TERP). 

Top 10 Safest Stocks To Watch Right Now: U.S. Auto Parts Network, Inc.(PRTS)

Advisors' Opinion:

• [By Max Byerly]

  Media stories about U.S. Auto Parts Network (NASDAQ:PRTS) have trended somewhat positive recently, Accern Sentiment Analysis reports. Accern scores the sentiment of news coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. U.S. Auto Parts Network earned a news impact score of 0.16 on Accern’s scale. Accern also gave media headlines about the specialty retailer an impact score of 47.0744515537091 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

• [By Joseph Griffin]

  Get a free copy of the Zacks research report on U.S. Auto Parts Network (PRTS)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Logan Wallace]

  Media stories about U.S. Auto Parts Network (NASDAQ:PRTS) have been trending somewhat positive recently, according to Accern Sentiment Analysis. The research firm scores the sentiment of media coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. U.S. Auto Parts Network earned a news sentiment score of 0.05 on Accern’s scale. Accern also assigned media stories about the specialty retailer an impact score of 45.533280416614 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near future.

Top 10 Safest Stocks To Watch Right Now: First Trust Dorsey Wright Focus 5 ETF(FV)

Advisors' Opinion:

• [By Max Byerly]

  Envestnet Asset Management Inc. lifted its holdings in shares of First Trust Dorsey Wright Focus 5 ETF (NASDAQ:FV) by 3.7% in the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 106,289 shares of the company’s stock after buying an additional 3,752 shares during the quarter. Envestnet Asset Management Inc.’s holdings in First Trust Dorsey Wright Focus 5 ETF were worth $3,132,000 as of its most recent filing with the SEC.